Table 1 Clinicopathological characteristics of 10 patients
PDO | Age | Menopausal | Location | Histological type | ER* | PgR* | HER2 | Grade | Ki67 | LVI** |
|---|---|---|---|---|---|---|---|---|---|---|
154 | 53 | Pre | Breast | IDC*** | 4 + 2 | 3 + 2 | + | 3 | 55% | + |
155 | 51 | Pre | Breast | IDC | 0 + 0 | 1 + 1 | + | 3 | 95% | + |
165 | 41 | Pre | Breast | IDC > IMPCa*** | 5 + 3 | 5 + 3 | − | 3 | 35% | + |
166 | 48 | Pre | Breast | IDC | 0 + 0 | 0*0 | + | 3 | 65% | − |
180 | 32 | Pre | Breast | IDC | 5 + 3 | 5 + 3 | − | 1 | 25% | + |
195 | 46 | Pre | Breast | IDC | 5 + 2 | 5 + 3 | − | 2 | 10% | − |
202 | 45 | Pre | Breast | IDC | 5 + 3 | 4 + 3 | − | 2 | 35% | − |
203 | 53 | Post | Breast | IMPCa > IDC | 5 + 2 | 4 + 3 | − | 1 | 5% | − |
207P | 52 | Post | Pleural effusion | Adenocarcinoma | N/A† | N/A† | N/A† | N/A† | N/A† | N/A |
210 | 47 | Pre | Chest wall | IDC | 4 + 2 | 4 + 2 | − | 3 | 90% | − |